Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation.

Cited by (366)

Items 101–200 of 366

1. Retroviral gene therapy in ApoE-deficient mice: ApoE expression in the artery wall reduces early foam cell lesion formation
   Hasty, Alyssa H., Linton, MacRae F., Brandt, Stephen J., Babaev, Vladimir R., Gleaves, Linda A., Fazio, Sergio · 1999 · Circulation
2. ApoE, Alzheimer's Disease, and Recovery from Brain Stressa
   Allen D. Roses, Ann M. Saunders · 1997 · Annals of the New York Academy of Sciences
3. Endothelial LRP1 – A Potential Target for the Treatment of Alzheimer’s Disease
   Steffen E. Storck, Claus U. Pietrzik · 2017 · Pharmaceutical Research
4. Differential Generation of High‐Density Lipoprotein by Endogenous and Exogenous Apolipoproteins in Cultured Fetal Rat Astrocytes
   Jin‐ichi Ito, Li‐Yong Zhang, Michiyo Asai, Shinji Yokoyama · 1999 · Journal of Neurochemistry
5. The role of apolipoprotein E in lipid metabolism in the central nervous system
   Xian-Lin Han · 2004 · Cellular and Molecular Life Sciences
6. Hypomorphic Apolipoprotein E Mice
   Robert L. Raffaı̈, Karl Heinrich Weisgraber · 2002 · Journal of Biological Chemistry
7. Intraventricular Infusion of Apolipoprotein E Ameliorates Acute Neuronal Damage after Global Cerebral Ischemia in Mice
   Karen J. Horsburgh, James McCulloch, Margaret Nilsen, Eileen McCracken, Charles H. Large, Allen D. Roses, James A. R. Nicoll · 2000 · Journal of Cerebral Blood Flow & Metabolism
8. Measurement of human apolipoprotein B-48 and B-100 kinetics in triglyceride-rich lipoproteins using [5,5,5-2H3]leucine.
   Alice Hinda Lichtenstein, DL Hachey, JS Millar, JL Jenner, L Booth, José María Ordovás, Ernst J. Schaefer · 1992 · Journal of Lipid Research
9. Apolipoprotein E in Alzheimer’s disease trajectories and the next-generation clinical care pathway
   Sneha Narasimhan, David M. Holtzman, Liana G. Apostolova, Carlos Cruchaga, Colin Louis Masters, John Hardy, Victor L. Villemagne, J. Simon Bell, Min Cho, Harald Juergen Hampel · 2024 · Nature Neuroscience
10. Prevention of stroke and dementia by statin therapy: Experimental and clinical evidence of their pleiotropic effects
    Takashi Miida, Akihiro Takahashi, Takeshi Ikeuchi · 2006 · Pharmacology & Therapeutics
11. Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease
    Simona Vuletic, Lee‐Way Jin, Santica M. Marcovina, Elaine R. Peskind, Thomas Mo ̈ller, John J. Albers · 2003 · Journal of Lipid Research
12. APOE ε3/ε4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer’s disease diagnosis
    Fukumoto, Hiroaki, Ingelsson, Martin, Gårevik, Nina, Wahlund, Lars-Olof, Nukina, Nobuyuki, Yaguchi, Yoshio, Shibata, Masao, Hyman, Bradley T., Rebeck, G.William, Irizarry, Michael C. · 2003 · Experimental Neurology
13. The Interaction of Amyloid-β with ApoE
    Donald B. Carter · 2005 · Sub-cellular biochemistry/Subcellular biochemistry
14. An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer’s disease pathology following closed head injury: Evidence of pharmacogenomic interaction
    Huanfei Wang, L. Durham, Hana N. Dawson, Pingping Song, David S. Warner, Patrick M. Sullivan, Michael Peter Vitek, Daniel T. Laskowitz · 2006 · Neuroscience
15. APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure
    Lynn M. Bekris, Nichole M. Galloway, Thomas Jude Montine, Gerard D. Schellenberg, Chang‐En Yu · 2009 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
16. Peripheral Versus Central Nervous System APOE in Alzheimer’s Disease: Interplay across the Blood-Brain Barrier
    Dustin Chernick, Stephanie Ortiz-Valle, Angela Jeong, Wenhui Qu, Ling Li · 2019 · Neuroscience Letters
17. The small HDL particle hypothesis of Alzheimer's disease
    Ashley E. Martinez, Gali H. Weissberger, Zsuzsanna Kuklenyik, Xulei He, Cristiana Joy Meuret, Trusha Parekh, Jon C. Rees, Bryan A. Parks, Michael S. Gardner, Sarah M. King et al. · 2022 · Alzheimer s & Dementia
18. Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease
    Aksam J. Merched, Hubert Blain, Sophie Visvikis‐Siest, Bernard Herbeth, Claude Jeandel, Gérard Siest · 1997 · Journal of the Neurological Sciences
19. Cholesterol at the crossroads: Alzheimer's disease and lipid metabolism
    Cheryl Lea Wellington · 2004 · Clinical Genetics
20. Apolipoprotein E and Neurological Disease: Therapeutic Potential and Pharmacogenomic Interactions
    Daniel T. Laskowitz, Michael Peter Vitek · 2007 · Pharmacogenomics
21. Localization of a liver-specific enhancer in the apolipoprotein E/C-I/C-II gene locus
    Neil S. Shachter, Yijun Zhu, A Walsh, Jan L. Breslow, JD Smith · 1993 · Journal of Lipid Research
22. Genetic Factors in Outcome After Traumatic Brain Injury
    Ramon R. Diaz-Arrastia, Victoria Kate Baxter · 2006 · Journal of Head Trauma Rehabilitation
23. Differential effects of simvastatin and pravastatin on expression of Alzheimer's disease-related genes in human astrocytes and neuronal cells
    Weijiang Dong, Simona Vuletic, John J. Albers · 2009 · Journal of Lipid Research
24. Human Central Nervous System (CNS) ApoE Isoforms Are Increased by Age, Differentially Altered by Amyloidosis, and Relative Amounts Reversed in the CNS Compared with Plasma
    Baker-Nigh, Alaina T., Mawuenyega, Kwasi G., Bollinger, James G., Ovod, Vitaliy, Kasten, Tom, Franklin, Erin E., Liao, Fan, Jiang, Hong, Holtzman, David, Cairns, Nigel J. et al. · 2016 · Journal of Biological Chemistry
25. Neuroprotective pentapeptide CN-105 is associated with reduced sterile inflammation and improved functional outcomes in a traumatic brain injury murine model
    Daniel T. Laskowitz, Haichen Wang, Tony Chen, David T. Lubkin, Viviana Cantillana, Tian Ming Tu, Dawn Kernagis, Guanen Zhou, Gary Macy, Brad J. Kolls et al. · 2017 · Scientific Reports
26. ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-β pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis
    Fagan, Anne M., Christopher, Erin, Taylor, Jennie W., Parsadanian, Maia, Spinner, Michael, Watson, Melanie, Fryer, John D., Wahrle, Suzanne, Bales, Kelly R., Paul, Steven M. et al. · 2004 · The American Journal of Pathology
27. In Vivo Human Apolipoprotein E Isoform Fractional Turnover Rates in the CNS
    Wildsmith, Kristin R., Basak, Jacob M., Patterson, Bruce W., Pyatkivskyy, Yuriy, Kim, Jungsu, Yarasheski, Kevin E., Wang, Jennifer X., Mawuenyega, Kwasi G., Jiang, Hong, Parsadanian, Maia et al. · 2012 · PLoS ONE
28. The Role of Apolipoprotein E in Guillain-Barré Syndrome and Experimental Autoimmune Neuritis
    Hongliang Zhang, Jiang Wu, Jie Zhu · 2010 · BioMed Research International
29. Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study
    Arjen J. C. Slooter, Peter de Knijff, Albert Hofman D, Marc Cruts, Monique M.B. Breteler, Christine Van Broeckhoven, Louis M. Havekes, Cornelia M. van Duijn · 1998 · Neuroscience Letters
30. Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation
    Eiron Cudaback, Xianwu Li, Yue Yang, Thomas B. Yoo, Kathleen S. Montine, Suzanne Craft, Thomas Jude Montine, Christopher Dirk Keene · 2012 · Journal of Neuroinflammation
31. Pharmacogenomic Effects of Apolipoprotein E on Intracerebral Hemorrhage
    Michael Lucas James, Patrick M. Sullivan, Christopher D. Lascola, Michael Peter Vitek, Daniel T. Laskowitz · 2008 · Stroke
32. Remodeling of Cerebrospinal Fluid Lipoprotein Particles after Human Traumatic Brain Injury
    Andrew D. Kay, Stephen Day, Mary Kerr, James A. R. Nicoll, Chris J. Packard, MURIEL J. CASLAKE · 2003 · Journal of Neurotrauma
33. Role of adipocyte-derived apoE in modulating adipocyte size, lipid metabolism, and gene expression in vivo
    Zhihua Huang, DeSheng Gu, Theodore Mazzone · 2009 · American Journal of Physiology-Endocrinology and Metabolism
34. Brain region‐specific up‐regulation of mouse apolipoprotein E by pharmacological estrogen treatments
    Justine A. Levin-Allerhand, Bruce S. McEwen, Chris E. Lominska, Dennis B. Lubahn, Kenneth Steven Korach, Jonathan D. Smith · 2001 · Journal of Neurochemistry
35. Decreased Cerebrospinal Fluid Apolipoprotein E After Subarachnoid Hemorrhage
    Andrew Kay, Axel Petzold, Mary Kerr, Geoff Keir, E J Thompson, James A. R. Nicoll · 2003 · Stroke
36. Macrophages, lipoprotein metabolism, and atherosclerosis: insights from murine bone marrow transplantation studies
    Linton, MacRae F., Fazio, Sergio · 1999 · Current Opinion in Lipidology
37. Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment‐associated cytotoxicity
    Izumi Maezawa, Lee‐Way Jin, Randall L. Woltjer, Nobuyo Maeda, George M. Martin, Thomas Jude Montine, Kathleen S. Montine · 2004 · Journal of Neurochemistry
38. Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides*
    M. Castro Cabezas, D.W. Erkelens, L A Kock, Tjerk WA de Bruin · 1994 · European Journal of Clinical Investigation
39. Apolipoprotein B gene mutations affecting cholesterol levels
    Robert V. Farese, MF Linton, Stephen G. Young · 1992 · Journal of Internal Medicine
40. COG1410 Improves Cognitive Performance and Reduces Cortical Neuronal Loss in the Traumatically Injured Brain
    M. Hoane, Nicholas A. Kaufman, M. Vitek, S. McKenna · 2009 · Journal of Neurotrauma
41. Advances in high-density lipoprotein physiology: surprises, overturns, and promises
    Caterina Constantinou, Eleni A. Karavia, Eva Xepapadaki, Περιστέρα-Ιωάννα Πετροπούλου, Ευγενία Παπακώστα, Marilena Karavyraki, Evangelia Zvintzou, Vassilis Theodoropoulos, Serafoula Filou, Aikaterini Hatziri et al. · 2015 · American Journal of Physiology-Endocrinology and Metabolism
42. ApoE expression in macrophages communicates immunometabolic signaling that controls hyperlipidemia‐driven hematopoiesis & inflammation via extracellular vesicles
    Tuan Anh Phu, Martin Ng, Ngan K. Vu, Alex S. Gao, Robert L. Raffaı̈ · 2023 · Journal of Extracellular Vesicles
43. Proposed mechanism for lipoprotein remodelling in the brain
    Chunjiang Yu, Katherine L. Youmans, Mary Jo LaDu · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
44. Intrathecal administration of a novel apoE-derived therapeutic peptide improves outcome following perinatal hypoxic–ischemic injury
    Jessica D. McAdoo, David S. Warner, Ron N. Goldberg, Michael Peter Vitek, Robert D. Pearlstein, Daniel T. Laskowitz · 2005 · Neuroscience Letters
45. COG1410, a novel apolipoprotein‐E mimetic, improves functional and morphological recovery in a rat model of focal brain ischemia
    Elena A. Tukhovskaya, Alexey Yu. Yukin, Oksana N. Khokhlova, Arkady N. Murashev, Michael Peter Vitek · 2008 · Journal of Neuroscience Research
46. Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer’s disease
    Giannisis, Andreas, Al-Grety, Asma, Carlsson, Henrik, Patra, Kalicharan, Twohig, Daniel, Sando, Sigrid Botne, Lauridsen, Camilla, Berge, Guro, Grøntvedt, Gøril Rolfseng, Bråthen, Geir et al. · 2022 · Alzheimer's Research & Therapy
47. Sialylated Human Apolipoprotein E (apoEs) Is Preferentially Associated with Neuron-Enriched Cultures from APOE Transgenic Mice
    Pu‐Ting Xu, Donald E. Schmechel, Hui-Ling Qiu, Michael H. Herbstreith, Tracie Rothrock‐Christian, Michele V. Eyster, Allen D. Roses, John R. Gilbert · 1999 · Neurobiology of Disease
48. The Cell Biology and Physiologic Relevance of ApoE Recycling
    Sergio Fazio · 2000 · Trends in Cardiovascular Medicine
49. Administration of COG1410 Reduces Axonal Amyloid Precursor Protein Immunoreactivity and Microglial Activation after Controlled Cortical Impact in Mice
    Yong Qing Jiang, David L. Brody · 2012 · Journal of Neurotrauma
50. Impact of apolipoprotein E genetic polymorphisms on liver disease: An essential review
    José Carlos Rodrigues Nascimento, Gabriella Araújo Matos, Lianna Cavalcante Pereira, Anderson Emanuel Caliope Castelo Branco Mourão, Aline Menezes Sampaio, Reinaldo B. Oriá, Pierluigi Toniutto · 2019 · Annals of Hepatology
51. Characterization of Apolipoprotein E-containing Lipoproteins in Cerebrospinal Fluid: Effect of Phenotype on the Distribution of Apolipoprotein E
    Kazuyoshi Yamauchi, Minoru Tozuka, Hiroya Hidaka, Eiko Hidaka, Yoshiyuki Kondo, Tsutomu Katsuyama · 1999 · Clinical Chemistry
52. Links between copper and cholesterol in Alzheimer's disease
    Ya-Hui Hung, A. Bush, S. La Fontaine · 2013 · Frontiers in Physiology
53. Pyrene Fluorescence Analysis Offers New Insights into the Conformation of the Lipoprotein-Binding Domain of Human Apolipoprotein E
    Arti Patel, Panupon Khumsupan, Vasanthy Narayanaswami · 2010 · Biochemistry
54. Generation and function of astroglial lipoproteins from Niemann–Pick type C1-deficient mice
    Barbara Karten, Hideki Hayashi, Gordon A. Francis, Robert B. Campenot, Dennis E. Vance, Jean E. Vance · 2005 · Biochemical Journal
55. Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders
    Turri, Marta, Marchi, Cinzia, Adorni, Maria Pia, Calabresi, Laura, Zimetti, Francesca · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
56. Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia
    Tetiana Poliakova, Cheryl Lea Wellington · 2023 · Molecular Neurodegeneration
57. Lipid-Binding Proteins in Brain Health and Disease
    Miriam Corraliza-Gómez, Diego Sánchez, María Dolores Ganfornina · 2019 · Frontiers in Neurology
58. Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins
    Kathleen S. Montine, Casey N. Bassett, Joyce J. Ou, William R. Markesbery, Larry L. Swift, Thomas Jude Montine · 1998 · Journal of Lipid Research
59. Elimination of macrophage-specific apolipoprotein E reduces diet-induced atherosclerosis in C57BL/6J male mice
    William A. Boisvert, Linda K. Curtiss · 1999 · Journal of Lipid Research
60. Brain integrity is altered by hepatic APOE ε4 in humanized-liver mice
    Andreas Giannisis, Kalicharan Patra, Anna K. Edlund, Lur Agirrezabala Nieto, Joan Benedicto-Gras, Simon Moussaud, Andrés de la Rosa, Daniel Twohig, Tore Bengtsson, Yuan Fu et al. · 2022 · Molecular Psychiatry
61. The vascular contribution of apolipoprotein E to Alzheimer’s disease
    Feng Chen, Jing Zhao, Fanxia Meng, Fangping He, Jie Ni, Yuan Fu · 2024 · Brain
62. ApoE mimetic improves pathology and memory in a model of Alzheimer’s disease
    Krishnamurthy, Kamesh, Cantillana, Viviana, Wang, Haichen, Sullivan, Patrick M., Kolls, Bradley J., Ge, Xintong, Lin, Yufeng, Mace, Brian, Laskowitz, Daniel T. · 2020 · Brain Research
63. Brain cholesterol homeostasis and its association with neurodegenerative diseases
    Gao, Yi, Ye, Shiying, Tang, Yuehong, Tong, Wenjuan, Sun, Shaowei · 2023 · Neurochemistry International
64. Cholesterol in the CNS: functions, recycling and remyelination
    Emily C. Wuerch, Voon Wee Yong · 2025 · Journal of Neuroinflammation
65. Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease
    Richard Kennedy, Gary Cutter, Lon S. Schneider · 2013 · Alzheimer s & Dementia
66. Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer’s Disease
    Per Johansson, Erik G. Almqvist, Maria Bjerke, Anders Wallin, Jan-Ove Johansson, Ulf Andréasson, Kaj Blennow, Henrik Zetterberg, Johan Svensson · 2017 · Journal of Alzheimer s Disease
67. The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
    Dustin Chernick, Rui Zhong, Ling Li · 2020 · Biomolecules
68. Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis
    Junjie Wei, Ming‐Hua Zheng, Peixiao Liang, Yunfei Wei, Xiaoduan Yin, Yulan Tang, Yimin Xue · 2013 · Neurobiology of Disease
69. Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein: A nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid
    Panupon Khumsupan, Ricardo Ramírez, Darin Khumsupan, Vasanthy Narayanaswami · 2010 · Biochimica et Biophysica Acta (BBA) - Biomembranes
70. Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury
    Xiaoxin Cheng, Yiyan Zheng, Ping Bu, Xiangbei Qi, Chunling Fan, Fengqiao Li, Dong Kim, Qilin Cao · 2017 · Experimental Neurology
71. Abnormalities of Apolipoprotein E in the Acquired Immunodeficiency Syndrome
    Carl Grünfeld, William T. Doerrler, Miyin Pang, Peter Jensen, Karl Heinrich Weisgraber, Kenneth R. Feingold · 1997 · The Journal of Clinical Endocrinology & Metabolism
72. Hepatocyte-derived ApoE Is More Effective than Non-hepatocyte-derived ApoE in Remnant Lipoprotein Clearance
    Robert L. Raffaı̈, Alyssa H. Hasty, Yuwei Wang, Shelley E. Mettler, David A. Sanan, MacRae F. Linton, Sergio Fazio, Karl Heinrich Weisgraber · 2003 · Journal of Biological Chemistry
73. Apolipoprotein E in Cerebrospinal Fluid in 85-Year-Old Subjects
    Ingmar Gr. Skoog · 1997 · Archives of Neurology
74. Lipid and lipoprotein metabolism in microglia: Alzheimer’s disease mechanisms and interventions
    Kayla G. Sprenger, Emma E Lietzke, John Melchior, Kimberley D. Bruce · 2025 · Journal of Lipid Research
75. ApoE4 Delays Dendritic Spine Formation during Neuron Development and Accelerates Loss of Mature Spines in Vitro
    Evelyn Nwabuisi‐Heath, George William Rebeck, Mary Jo LaDu, Chunjiang Yu · 2013 · ASN NEURO
76. Understanding the Exchange of Systemic HDL Particles Into the Brain and Vascular Cells Has Diagnostic and Therapeutic Implications for Neurodegenerative Diseases
    Juno S. Van Valkenburgh, Cristiana Joy Meuret, Ashley E. Martinez, Vibha Kodancha, Victoria A. Solomon, Kai Chen, Hussein N. Yassine · 2021 · Frontiers in Physiology
77. Association of Apolipoprotein E in Lipoprotein Subspecies With Risk of Dementia
    Koch, Manja, DeKosky, Steven T., Goodman, Matthew, Sun, Jiehuan, Furtado, Jeremy D., Fitzpatrick, Annette L., Mackey, Rachel H., Cai, Tianxi, Lopez, Oscar L., Kuller, Lewis H. et al. · 2020 · JAMA Network Open
78. ApolipoproteinE mimetic peptides improve outcome after focal ischemia
    Haichen Wang, Lauren G. Anderson, Christopher D. Lascola, Michael Lucas James, Talaignair N. Venkatraman, Ellen R. Bennett, Shawn K. Acheson, Michael Peter Vitek, Daniel T. Laskowitz · 2012 · Experimental Neurology
79. Diet and Age Interactions with Regards to Cholesterol Regulation and Brain Pathogenesis
    Romina María Uranga, Jeffrey N. Keller · 2010 · Current Gerontology and Geriatrics Research
80. Dysregulation of Neuronal Nicotinic Acetylcholine Receptor–Cholesterol Crosstalk in Autism Spectrum Disorder
    Ana Sofía Vallés, Francisco José Barrantes · 2021 · Frontiers in Molecular Neuroscience
81. Astrocyte׳s endogenous apoE generates HDL-like lipoproteins using previously synthesized cholesterol through interaction with ABCA1
    Jin‐ichi Ito, Yuko Nagayasu, Yutaka Miura, Shinji Yokoyama, Makoto Michikawa · 2014 · Brain Research
82. Astrocytes produce and secrete FGF-1, which promotes the production of apoE-HDL in a manner of autocrine action
    Jin‐ichi Ito, Yuko Nagayasu, Rui Lu, Alireza Kheirollah, Michi Hayashi, Shinji Yokoyama · 2005 · Journal of Lipid Research
83. COG1410, an Apolipoprotein E-based Peptide, Improves Cognitive Performance and Reduces Cortical Loss Following Moderate Fluid Percussion Injury in the Rat
    Nicholas A. Kaufman, Jason E Beare, A. Tan, M. Vitek, S. McKenna, M. Hoane · 2010 · Behavioural Brain Research
84. Cerebrospinal fluid apolipoprotein E concentration decreases after traumatic brain injury
    Kay, Andrew D., Petzold, Axel, Kerr, Mary, Keir, Geoff, Thompson, Ed J., Nicoll, James A.R. · 2003 · Journal of Neurotrauma
85. Human apolipoprotein E allele-specific brain expressing transgenic mice
    Jonathan D. Smith, John L. Sikes, Justine A. Levin-Allerhand · 1998 · Neurobiology of Aging
86. Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma
    Koch, Manja, Furtado, Jeremy D., Falk, Kim, Leypoldt, Frank, Mukamal, Kenneth J., Jensen, Majken K. · 2017 · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
87. Liver Transplant Pathology in Pediatric Metabolic Disorders
    Ronald Jaffe · 1998 · Pediatric and Developmental Pathology
88. Potential Role of apoE in Structural Plasticity in the Nervous System
    David M. Holtzman, Anne M. Fagan · 1998 · Trends in Cardiovascular Medicine
89. Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes
    Kalyane Bach‐Ngohou, Khadija Ouguerram, Hassan Nazih, Pascale Maugère, Blanca Ripollés Piquer, Yassine Zaïr, R. Frénais, Michel Krempf, Jean‐Marie Bard · 2002 · International Journal of Obesity
90. Role of cholesterol in amyloid cascade: cholesterol‐dependent modulation of tau phosphorylation and mitochondrial function
    M. Michikawa · 2006 · Acta Neurologica Scandinavica, Supplementum
91. Identification of a novel enhancer of brain expression near the apoE gene cluster by comparative genomics
    Ping Zheng, Len A. Pennacchio, Wilfried Le Goff, Edward M. Rubin, Jonathan D. Smith · 2003 · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
92. Effect of Macrophage-Derived Apolipoprotein E on Established Atherosclerosis in Apolipoprotein E–Deficient Mice
    Weibin Shi, Xuping Wang, Nicholas J. Wang, William H. McBride, Aldons Jake Lusis · 2000 · Arteriosclerosis Thrombosis and Vascular Biology
93. Differential effects of apoE4 and activation of ABCA1 on brain and plasma lipoproteins
    Boehm-Cagan, Anat, Bar, Roni, Harats, Dror, Shaish, Aviv, Levkovitz, Hana, Bielicki, John K., Johansson, Jan O., Michaelson, Daniel M. · 2016 · PLOS ONE
94. The Role of ApoE Expression and Variability of Its Glycosylation in Human Reproductive Health in the Light of Current Information
    Monika Kacperczyk, Agnieszka Kmieciak, Ewa Maria Kratz · 2021 · International Journal of Molecular Sciences
95. Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E
    Jérôme Robert, Emily B. Button, Emma M. Martin, Luke McAlary, Zoe Gidden, Megan Gilmour, Guilaine K. Boyce, Tara M. Caffrey, Andrew M. Agbay, Amanda Clark et al. · 2020 · Molecular Neurodegeneration
96. Model Membranes and Their Interactions with Native and Artificial Lipoproteins
    Sarah Waldie · 2020
97. Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?
    Vecchio, Filomena Lo, Bisceglia, Paola, Imbimbo, Bruno Pietro, Lozupone, Madia, Latino, Raffaela Rita, Resta, Emanuela, Leone, Maurizio, Solfrizzi, Vincenzo, Greco, Antonio, Daniele, Antonio et al. · 2022 · Therapeutic Advances in Chronic Disease
98. Human cerebrospinal fluid contains diverse lipoprotein subspecies enriched in proteins implicated in central nervous system health
    Merrill, Nathaniel J., Davidson, W. Sean, He, Yi, Díaz Ludovico, Ivo, Sarkar, Snigdha, Berger, Madelyn R., McDermott, Jason E., Van Eldik, Linda J., Wilcock, Donna M., Monroe, Matthew E. et al. · 2023 · Science Advances
99. Current Perspectives: Obesity and Neurodegeneration - Links and Risks
    Paul J. Kueck, Jill K. Morris, John A. Stanford · 2024 · Degenerative Neurological and Neuromuscular Disease
100. Therapeutic Effects of Fibrates in Postprandial Lipemia
     Genovefa D. Kolovou, Peggy M Kostakou, Katherine K. Anagnostopoulou, Dennis V. Cokkinos · 2008 · American Journal of Cardiovascular Drugs